TickerFacts.

Company research / MCK

McKesson Corp (MCK)

Build a valuation ↗↓ Download CSV

SEC name MCKESSON CORP · CIK 0000927653 · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

  • Sector Wholesale Trade
  • Incorporated DE
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, McKesson Corp reported revenue of $403.43B. Revenue grew 12.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $410.98B.

Key ratios (year ended 2026-03-31)

3.6%
Gross margin
1.5%
Operating margin
1.2%
Net margin
12.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Headquarters locality: Irving · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenue$410.98B$403.43B$359.05B$308.95B$276.71B$263.97B$238.23B$231.05B$214.32B$208.36B$198.53B
Cost of Revenue$396.03B$388.88B$345.73B$296.12B$264.35B$250.84B$226.08B$219.03B$202.56B$197.17B$187.26B
Gross Profit$14.96B$14.55B$13.32B$12.83B$12.36B$13.13B$12.15B$12.02B$11.75B$11.18B$11.27B
R&D Expensen/an/an/an/an/an/an/a$96.00M$71.00M$125.00M$341.00M
Operating Income$6.50B$6.21B$4.42B$3.91B$4.38B$2.04B-$5.04B$2.49B$886.00M$762.00M$7.12B
Depreciation & Amortization$767.00M$729.00M$636.00M$635.00M$608.00M$760.00M$887.00M$922.00M$949.00M$951.00M$910.00M
EBITDA$7.26B$6.94B$5.06B$4.54B$4.99B$2.80B-$4.15B$3.41B$1.83B$1.71B$8.03B
Net Income$4.59B$4.76B$3.29B$3.00B$3.56B$1.11B-$4.54B$900.00M$34.00M$67.00M$5.07B
EPS (Diluted)n/a$38.38$25.72$22.39$25.03$7.23-$28.26$4.95$0.17$0.32$22.73
Total Assets$88.33B$82.32B$75.14B$67.44B$62.32B$63.30B$65.02B$61.25B$59.67B$60.38B$60.97B
Long-Term Debt$9.73B$6.53B$5.65B$5.63B$5.59B$5.88B$7.15B$7.39B$7.59B$7.88B$8.36B
Shareholders' Equity-$3.86B-$1.78B-$1.69B-$1.60B-$1.49B-$1.79B$175.00M$5.31B$8.29B$10.06B$11.27B
Cash & Equivalents$5.16B$3.98B$5.69B$4.58B$4.68B$3.53B$6.28B$4.01B$2.98B$2.67B$2.78B
Operating Cash Flow$6.85B$6.16B$6.08B$4.31B$5.16B$4.43B$4.54B$4.37B$4.04B$4.34B$4.74B
Capital Expenditures$437.00M$436.00M$537.00M$431.00M$390.00M$388.00M$451.00M$362.00M$426.00M$405.00M$404.00M
Free Cash Flow$6.42B$5.72B$5.55B$3.88B$4.77B$4.05B$4.09B$4.01B$3.61B$3.94B$4.34B
Share Repurchases$6.70B$4.75B$3.15B$3.02B$3.64B$3.52B$742.00M$1.93B$1.64B$1.71B$2.31B
Dividends Paid$393.00M$381.00M$345.00M$314.00M$292.00M$277.00M$276.00M$294.00M$292.00M$262.00M$253.00M
Dividends Per Sharen/a$3.17$2.75$2.40$2.09$1.83$1.67$1.62$1.51$1.30$1.12
Weighted Average Diluted Sharesn/a124.10M128.10M134.10M142.20M154.10M160.60M181.60M197.30M209.00M223.00M
EPS (Basic)n/a$38.55$25.86$22.54$25.23$7.32-$28.26$4.98$0.17$0.32$22.95

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView